Author:
Bartholeyns J,Bardot V,Chokri M,Romet-Lemonne J.L
Subject
Gastroenterology,Internal Medicine
Reference52 articles.
1. Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2;Lafreniere;Cancer Res,1985
2. Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and non immunogenic sarcomas and adenocarcinoma;Lafreniere;J. Immunol,1985
3. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2;Rosenberg;JAMA,1994
4. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone;Rosenberg;N Engl J M,1987
5. Treatment of reccurrent in transit metastases from cutaneous melanoma by isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine-activated killer cells: a pilot study;Belli;Melanoma Res,1992
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献